Gene Therapy for HIV and Chronic Infections

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Genetics
Cover of the book Gene Therapy for HIV and Chronic Infections by , Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781493924325
Publisher: Springer New York Publication: March 10, 2015
Imprint: Springer Language: English
Author:
ISBN: 9781493924325
Publisher: Springer New York
Publication: March 10, 2015
Imprint: Springer
Language: English

This book centers  on gene therapy and gene transfer approaches to prevent or treat chronic virus infections. The main focus is on the Big Three: human immunodeficiency virus (HIV-1), hepatitis B virus (HBV) and hepatitis C virus (HCV). Ample anti-HIV drugs are currently available in the clinic and the development of an effective combination therapy has dramatically improved the lifespan and quality of life of infected individuals. A similar trend can already be recognized for HBV and HCV: the development of multiple (directly acting) antiviral drugs and plans to control or even cure the infection. However, approaches that help prevent infection, or which provide long-lasting treatment (such as a cure) remain important goals.   Immunization through gene transfer vehicles encoding immunogenic viral proteins shows promise in preventing infections with complex, highly variable, viruses such as HIV-1 or HCV. Gene therapy applications for virus infections have been discussed since the early 1990’s. Whereas a true cure seems difficult to achieve for HIV-1 due to its intrinsic property to deposit its genome into that of the host, such attempts may be within reach for HCV where spontaneous viral clearance occurs in a small percentage of the infected individuals. The prospect of original gene therapy approaches may provide alternative ways to reach the same endpoint by, for example, silencing of CCR5 expression post-transcriptionally. Many alternative antiviral strategies have been developed based on a variety of novel molecular methods: e.g. ribozymes. Some studies have progressed towards pre-clinical animal models and a few antiviral gene therapies have progressed towards clinical trials. This book provides an overview of this rapidly progressing field, while focusing on the interface of gene therapy and immunology/vaccinology.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book centers  on gene therapy and gene transfer approaches to prevent or treat chronic virus infections. The main focus is on the Big Three: human immunodeficiency virus (HIV-1), hepatitis B virus (HBV) and hepatitis C virus (HCV). Ample anti-HIV drugs are currently available in the clinic and the development of an effective combination therapy has dramatically improved the lifespan and quality of life of infected individuals. A similar trend can already be recognized for HBV and HCV: the development of multiple (directly acting) antiviral drugs and plans to control or even cure the infection. However, approaches that help prevent infection, or which provide long-lasting treatment (such as a cure) remain important goals.   Immunization through gene transfer vehicles encoding immunogenic viral proteins shows promise in preventing infections with complex, highly variable, viruses such as HIV-1 or HCV. Gene therapy applications for virus infections have been discussed since the early 1990’s. Whereas a true cure seems difficult to achieve for HIV-1 due to its intrinsic property to deposit its genome into that of the host, such attempts may be within reach for HCV where spontaneous viral clearance occurs in a small percentage of the infected individuals. The prospect of original gene therapy approaches may provide alternative ways to reach the same endpoint by, for example, silencing of CCR5 expression post-transcriptionally. Many alternative antiviral strategies have been developed based on a variety of novel molecular methods: e.g. ribozymes. Some studies have progressed towards pre-clinical animal models and a few antiviral gene therapies have progressed towards clinical trials. This book provides an overview of this rapidly progressing field, while focusing on the interface of gene therapy and immunology/vaccinology.

More books from Springer New York

Cover of the book HIV/AIDS in U.S. Communities of Color by
Cover of the book Management of Headache and Headache Medications by
Cover of the book Choosing and Using Astronomical Filters by
Cover of the book Lung Cancer Metastasis by
Cover of the book The Amateur Astronomer's Guide to the Deep-Sky Catalogs by
Cover of the book Dyslipidemias in Kidney Disease by
Cover of the book A Natural Experiment on Electoral Law Reform by
Cover of the book A Dictionary of Neurological Signs by
Cover of the book Measuring Race and Ethnicity by
Cover of the book Modeling the Interplay Between Human Behavior and the Spread of Infectious Diseases by
Cover of the book The Search for Certainty by
Cover of the book Computational Methods for Sensor Material Selection by
Cover of the book Health Care Advocacy by
Cover of the book Wafer-Level Chip-Scale Packaging by
Cover of the book Techniques for Nanoencapsulation of Food Ingredients by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy